Our findings strongly indicate that overexpression of TKTL1 is responsible for the observed tumour-specific effects of transketolase enzyme reactions, and represents the basis for the observed inhibition of proliferation of cancer cells by anti-transketolase approaches. This evidence concerns the gene TKT and cancer.